Addleshaw Goddard

Addleshaw Goddard LLP is an international law firm with offices in Ireland, the UK, France, Germany, Spain and The Middle East, providing a comprehensive legal service which is focused on delivering to clients commercial and pragmatic solutions to enable them to run their business more effectively and successfully. We have an expert team of people who have gained wide experience in diverse areas of law. This allows us to offer clients a specifically tailored service to deliver the commercially-focused solutions they require from a legal partner.

Enterprise Ireland

Enterprise Ireland (EI) is the state agency responsible for the development of Irish enterprises.   EI supports business at all stages of a growth to create solutions for global challenges, delivering sustainable prosperity throughout Ireland. 

Healthcare & Technology International - (HTI)

HTI is an Executive Search firms dedicated to Life Sciences in Europe, with strong focus on Medtech and innovative technologies. We have a particular affinity supporting start-up firms in building their operations, from early R&D, to market launch. We can also help optimize team dynamics and performance with HR services such as coaching and assessment of Management teams of VC-backed companies. 25 years experience and deep understanding of the healthcare industry sectors have enabled us to recruit C-suite and senior management as well as technical and scientific expert positions across all specialties.

Johnson & Johnson MedTech

Having made significant contributions to surgery for more than a century, the Johnson & Johnson Medical Devices Companies are in the business of reaching more patients and restoring more lives. The group represents the most comprehensive surgical technology and specialty solutions business in the world, offering an unparalleled breadth of products, services, programs and research and development capabilities directed at advancing patient care while delivering clinical and economic value to health care systems worldwide.

Medmarc

Medmarc was created in 1979 by the healthcare technology industry. Medmarc’s purpose is to be the superior provider of liability insurance and related risk management solutions and to support the development, testing and delivery of medical products that save lives and improve the quality of life. Through collaboration with our parent company, ProAssurance, and our clinical trial industry experts, we provide a single source of innovative healthcare liability insurance solutions to the life sciences companies we serve. 

Medtronic PLC

Headquartered in Dublin, Ireland, Medtronic is among the world’s largest medical technology, services and solutions companies – alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 88,000 people worldwide, serving physicians, hospitals and patients in approximately 160 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.

NAMSA

Helping medical device Sponsors improve healthcare since 1967, NAMSA is the world’s leading MedTech Contract Research Organization (CRO) offering global end-to-end development services. Driven by its global regulatory expertise and in-depth therapeutic knowledge, NAMSA is dedicated to accelerating medical device product development, offering only the most proven solutions to move clients’ products through the development life cycle efficiently and cost-effectively. From medical device testing; regulatory, reimbursement and quality consulting; and clinical research services; NAMSA is the industry’s premier, trusted partner for successful development and commercialization outcomes.

PRIA Healthcare

PRIA Healthcare is a leading full-spectrum reimbursement services and market access firm instrumental in supporting the successful commercialization and market adoption of over 300 medical devices since 2012. As a trusted partner to innovators and investors in MedTech, PRIA empowers the industry with the knowledge, tools, and strategies needed to navigate the complexities of the healthcare landscape.

Our team of experts in reimbursement, health economics, market access, patient access, and payer engagement provide guidance to medical device manufacturers of all sizes, supporting the entire product journey from concept development through long-term market adoption. Our holistic approach offers actionable insights and comprehensive tactical execution strategies that support patients’ access to healthcare innovation, today and into the future.

Let’s work together!  For additional information on how we can partner, please visit our website at www.PRIAHealthcare.com. 

Seroba Life Sciences

Seroba is a European life sciences venture capital firm focused on investing in winning innovations in biotech and medtech.  The team has deep investment and industry experience enabling Seroba to help entrepreneurs realise their ambitions whilst creating value for investors.  The firm has built a strong portfolio of investee companies across multiple indications. Seroba partners with entrepreneurs to create and build businesses around extraordinary science.

AdvaMed

AdvaMed is the leading trade association for the medical technology industry, offering an unparalleled platform for policy, advocacy, stakeholder engagement and professional development for medical technology companies. AdvaMed proudly represents 600 medtech companies of all sizes developing life-changing devices, diagnostic tests, and digital health technologies that serve millions of patients around the world. The association is committed to driving advancements in patient care, ensuring regulatory clarity, and provide a collaborative space for health care innovation to grow in an evolving industry.

Asabys Partners

Asabys is a Barcelona-based venture capital firm investing in healthcare across the board, between biopharma and health-tech. Founded in 2018 and with about €300M AUM, Asabys has recently closed its 2nd fund at €180M. Prior investments in medtech include Medlumics, Anaconda Biomed, Medasense, Inbrain Neuroelectronics and Gradient Denervation Technologies. Asabys is currently looking for new investments, seeking to back bold and visionary entrepreneurs developing technologies that have the potential to change the way diseases are treated and provide value to the healthcare ecosystem as much as the patients themselves.

CBSET Inc.

CBSET is a nonprofit biomedical research institution with a mission to advance the development of novel therapeutics and medical devices.  CBSET’s GLP-compliant facility offers AAALAC-accredited vivaria, well-equipped surgical and necropsy suites, dedicated space for interventional and cardiac procedures, full histopathology services, and advanced imaging modalities both in vivo and in vitro, all under robust regulatory oversight. 

Claret Capital Partners

Claret Capital Partners is Europe's largest independent growth debt fund manager. Since 2013, the Claret funds have invested over €1bn in over 180 European SMEs across the technology and life sciences sectors.  

 The team have been active in the technology financing markets for over 20 years and provide innovative debt solutions to help entrepreneurs and private equity investors grow their companies whilst minimising dilution.  

Claret has a long track record of investing in the MedTech, and broader Life Sciences sector - investments include Cambridge Cognition, Cardiac Dimensions, Cisiv, Deciphex, Endomag, HealthHero, Neurent Medical, NOVACYT, and SpineGuard.   

CS Lifesciences

CS Lifesciences is your go-to consultancy with a strong presence in the UK, Ireland, and the USA. We offer comprehensive Quality, Clinical, and Regulatory support for Medical Devices and IVD/Clinical Diagnostics. Our services guide companies through regulatory complexities, covering the US, EU, and UK. From product development to Quality Management System (QMS) setup, clinical and regulatory submissions, and post-market support, we have a proven track record in navigating FDA processes, obtaining CE marks, and acting as your EU/UK Authorised Representative, US Agent, and FDA Initial Importer.

Earlybird Venture Capital

Founded in 1997, Earlybird invests in all development and growth phases of technology companies. Among the most experienced venture investors in Europe, Earlybird offers its portfolio companies not only financial resources, but also strategic and operational support, as well as access to an international network and capital markets. With over EUR 1 billion under management, seven IPOs and 24 trade sales, Earlybird is one of the most successful venture capital firms in Europe.

EIT Health

EIT Health is a vast, vibrant community of world-leading health innovators backed by the European Union. EIT Health tackles Europe’s most pressing health challenges by collaborating across borders to connect the brightest minds from business, research, education, and healthcare, creating an environment where innovation thrives. 

Gilde Healthcare

Gilde Healthcare is a specialized healthcare investor managing €2 billion across two fund strategies: Venture & Growth and Private Equity. The firm operates out of offices in Utrecht (The Netherlands), Frankfurt (Germany) and Cambridge (United States). Gilde Healthcare Venture & Growth invests in fast growing, innovative companies active in (bio)pharmaceuticals, healthtech and medtech that are based in Europe and North America. For more information, please visit www.gildehealthcare.com.

Goodbody

Goodbody is a full service investment bank with a sector-led approach including a market leading equity capital markets (ECM) platform and research-led brand with a complementary ECM advisory business in UK and Ireland. We have a strong track record in capital raising, combining origination strength, structuring expertise and significant distribution capability globally. Goodbody is owned by AIB Group plc.

IQVIA MedTech

IQVIA MedTech, part of IQVIA, is a global strategic partner for accelerating MedTech innovation. By intelligently connecting the right insights, technology and MedTech expertise, we help enhance healthcare outcomes of the medical device and in vitro diagnostics industry. Our market leading and specialized solutions and services help boost product strategy with advanced data driven insights, optimize clinical success with accelerated trials and real‐world evidence, streamline efficient pathways for regulatory approvals, ensure compliance with comprehensive cloud‐based solutions and field recall, and maximize business performance with augmented team solutions along the complete product lifecycle.

Lifeblood Capital + Talent

Lifeblood is The MedTech Industry's Global Recruitment Firm. We are a team of physicians, engineers, MBAs, PhDs, MedTech investors, board members, and former executives who focus on recruiting talent and organizational consulting for MedTech startups, SMEs, and solution providers. Lifeblood recruits full-scale teams for MedTech companies at all levels from R&D through commercial phases while supporting international MedTech companies in building their US teams as they enter the US market. Our expertise is in recruiting board members, executives, and individual contributors, globally.

Lightstone Ventures

Lightstone Ventures is a global venture capital firm investing in Biotech and MedTech companies pioneering big ideas poised to transform patient outcomes. Lightstone Ventures was founded in 2012 to empower visionary entrepreneurs with the resources and operational guidance necessary to bring their innovative therapeutics and technologies to the patients who need them most. Lightstone Ventures' investment team has led deals resulting in 19 acquisitions and 20 initial public offerings over the last two decades. The firm has offices in Boston, Mass., Menlo Park, Calif., Dublin, Ireland and Singapore. For more information, visit www.lightstonevc.com.

Medidata is leading the digital transformation of life science, with the world’s most used platform for clinical development, commercial, and real-world data. Rave RTSM is the only fully pre-validated randomization and trial supply management solution that can be configured in minutes and enables mid-study changes with minimal downtime and no change orders. RTSM is built on Rave EDC, so there is no double data entry and minimal reconciliation expediting study start-up and study-close out. Rave RTSM streamlines your operations and provides real-time visibility for your study teams. 

Olympus Corporation

Olympus is a global medical device company specializing in endoscopy with a passion for transforming the future of healthcare. Given its commitment to making lives healthier, safer and more fulfilling, as well as its major presence in hospitals around the world, Olympus has a good reason to be invested in future developments that will better the experiences of providers and patients. The company is seeking partnerships and licensing relationships with early stage medical device startups worldwide, and is interested in endoscopes, laparoscopic devices, devices for minimally invasive surgery, and AI technologies across a wide range of specialties including ENT, gastrointestinal, respiratory, gynecology, and urology. To discover more about Olympus' technology needs, click here.